• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体和基因芯片在人肺鳞状细胞癌表达谱分析中的比较应用

Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma.

作者信息

Bartling Babett, Hofmann Hans-Stefan, Boettger Thomas, Hansen Gesine, Burdach Stefan, Silber Rolf-Edgar, Simm Andreas

机构信息

Department of Cardio-Thoracic Surgery, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany.

出版信息

Lung Cancer. 2005 Aug;49(2):145-54. doi: 10.1016/j.lungcan.2005.02.006.

DOI:10.1016/j.lungcan.2005.02.006
PMID:16022908
Abstract

Expression profiling by gene microarray techniques have been developed to predict malignant tissue but there are no experiences with the application of antibody arrays to identify malignancy-related proteins. Because altered protein patterns might also better interpret biological processes, we applied tumour samples from 12 patients with squamous cell lung carcinoma and individual lung tissue controls to antibody arrays spotted with 378 distinct monoclonal antibodies. Array analysis defined 20 proteins with higher and nine with lower abundance in lung tumours. Comparison with gene microarray data revealed that 31% of the differentially regulated proteins correlate with altered mRNA expression in squamous cell lung carcinomas, including PEX1, MKK7 and HDAC3 for up-regulated proteins. The histone deacetylase (HDAC) 3 was investigated in detail by immunoblot analysis showing that HDAC3 is indeed elevated in 92% of tumours (n=22/24; P<0.001). Thus, antibody microarrays can be useful for detection of some target proteins related to lung cancer.

摘要

基因微阵列技术的表达谱分析已被用于预测恶性组织,但在应用抗体阵列识别恶性肿瘤相关蛋白方面尚无经验。由于蛋白质模式的改变可能也能更好地解释生物学过程,我们将12例肺鳞状细胞癌患者的肿瘤样本及个体肺组织对照应用于点有378种不同单克隆抗体的抗体阵列。阵列分析确定了肺肿瘤中丰度较高的20种蛋白和丰度较低的9种蛋白。与基因微阵列数据比较显示,31%差异调节的蛋白与肺鳞状细胞癌中mRNA表达的改变相关,上调蛋白包括PEX1、MKK7和HDAC3。通过免疫印迹分析对组蛋白去乙酰化酶(HDAC)3进行了详细研究,结果显示92%的肿瘤(n = 22/24;P < 0.001)中HDAC3确实升高。因此,抗体微阵列可用于检测一些与肺癌相关的靶蛋白。

相似文献

1
Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma.抗体和基因芯片在人肺鳞状细胞癌表达谱分析中的比较应用
Lung Cancer. 2005 Aug;49(2):145-54. doi: 10.1016/j.lungcan.2005.02.006.
2
Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.通过在全球人类59,620元件寡核苷酸阵列上进行表达谱分析来鉴定和分类非小细胞肺癌中的差异表达基因。
Oncol Rep. 2006 Sep;16(3):587-95.
3
[Screening of molecular markers of lung squamous cell carcinoma by microarrays].[利用微阵列技术筛选肺鳞状细胞癌的分子标志物]
Zhonghua Zhong Liu Za Zhi. 2004 Nov;26(11):660-3.
4
Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.利用cDNA微阵列对头颈部鳞状细胞癌进行基因表达谱分析。
Int J Oncol. 2006 Sep;29(3):605-13.
5
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.吸烟与支气管上皮及非小细胞肺癌中癌症相关基因的表达
J Pathol. 2006 Oct;210(2):192-204. doi: 10.1002/path.2039.
6
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.癌-睾丸抗原淋巴细胞抗原6复合体基因座K是一种血清学生物标志物,也是肺癌和食管癌的治疗靶点。
Cancer Res. 2007 Dec 15;67(24):11601-11. doi: 10.1158/0008-5472.CAN-07-3243.
7
Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.肺鳞状细胞癌组织和分离细胞中细胞类型特异性图谱的表征
Lung Cancer. 2006 Aug;53(2):129-42. doi: 10.1016/j.lungcan.2006.04.015. Epub 2006 Jun 6.
8
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.基于人源微小RNA-205(hsa-miR-205)表达的诊断检测方法可区分肺鳞癌与非鳞非小细胞肺癌。
J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.
9
Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.透明质酸介导的运动性:口腔鳞状细胞癌的一个靶点。
Int J Oncol. 2008 May;32(5):1001-9.
10
Dysregulation of GIMAP genes in non-small cell lung cancer.非小细胞肺癌中GIMAP基因的失调
Lung Cancer. 2008 Dec;62(3):287-94. doi: 10.1016/j.lungcan.2008.03.021. Epub 2008 May 6.

引用本文的文献

1
The Role of HDAC3 in Pulmonary Diseases.HDAC3在肺部疾病中的作用。
Lung. 2025 Mar 17;203(1):47. doi: 10.1007/s00408-025-00798-3.
2
Acetyl-CoA: An interplay between metabolism and epigenetics in cancer.乙酰辅酶A:癌症中代谢与表观遗传学之间的相互作用
Front Mol Med. 2022 Nov 16;2:1044585. doi: 10.3389/fmmed.2022.1044585. eCollection 2022.
3
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer.超级增强子在肺癌中作为潜在治疗靶点的致病作用
Front Pharmacol. 2024 Apr 12;15:1383580. doi: 10.3389/fphar.2024.1383580. eCollection 2024.
4
The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.紧密连接蛋白桩蛋白和转录因子叉头框蛋白 O1 在人肺腺癌细胞 A549 和正常肺上皮细胞中的作用及调控机制。
Int J Mol Sci. 2024 Jan 24;25(3):1411. doi: 10.3390/ijms25031411.
5
Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours.组蛋白乙酰化相关长链非编码RNA:预测肺腺癌预后和免疫反应以及区分冷热肿瘤的潜在生物标志物
Front Immunol. 2023 Mar 17;14:1139599. doi: 10.3389/fimmu.2023.1139599. eCollection 2023.
6
DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine.从3P医学角度看,DNA和组蛋白修饰作为有效的诊断和治疗靶点以推进非小细胞肺癌的管理
EPMA J. 2022 Nov 2;13(4):649-669. doi: 10.1007/s13167-022-00300-6. eCollection 2022 Dec.
7
Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.靶向组蛋白去乙酰化酶-3 阻断胃癌上皮-间充质可塑性和转移扩散。
Cell Biol Toxicol. 2023 Oct;39(5):1873-1896. doi: 10.1007/s10565-021-09673-2. Epub 2022 Jan 1.
8
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases.组蛋白去乙酰化酶抑制剂:肿瘤治疗、免疫调节及肺部疾病的靶点
Transl Oncol. 2022 Feb;16:101312. doi: 10.1016/j.tranon.2021.101312. Epub 2021 Dec 16.
9
Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets.非小细胞肺癌中的组蛋白修饰:分子机制和治疗靶点。
Int J Mol Sci. 2021 Oct 28;22(21):11701. doi: 10.3390/ijms222111701.
10
Effects of histone deacetylase inhibitors Tricostatin A and Quisinostat on tight junction proteins of human lung adenocarcinoma A549 cells and normal lung epithelial cells.组蛋白去乙酰化酶抑制剂曲古抑菌素 A 和 Quisinostat 对人肺腺癌细胞 A549 和正常肺上皮细胞紧密连接蛋白的影响。
Histochem Cell Biol. 2021 Jun;155(6):637-653. doi: 10.1007/s00418-021-01966-1. Epub 2021 May 11.